✦ LIBER ✦

Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists

✍ Scribed by Henrich, T. J.; Lewine, N. R. P.; Lee, S.-H.; Rao, S. S. P.; Berro, R.; Gulick, R. M.; Moore, J. P.; Tsibris, A. M. N.; Kuritzkes, D. R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HIV-1 clones resistant to a small molecu

✍ Pavel Pugach; Andre J. Marozsan; Thomas J. Ketas; Elissa L. Landes; John P. Moor 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 572 KB

Neutralizing antibody and anti-retrovira

✍ Pavel Pugach; Thomas J. Ketas; Elizabeth Michael; John P. Moore 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 555 KB

An anti-CCR5 monoclonal antibody and sma

✍ Diana Safarian; Xavier Carnec; Fotini Tsamis; Francis Kajumo; Tatjana Dragic 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 526 KB

Inhibition of CCR5-mediated infection by

✍ Samantha Willey; Paul J. Peters; W. Matthew Sullivan; Patrick Dorr; Manos Perros 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 593 KB

Susceptibility of HIV Type 2 Primary Iso

✍ Espirito-Santo, Maria; Santos-Costa, Quirina; Calado, Marta; Dorr, Patrick; Azev 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 316 KB

The magnitude of HIV-1 resistance to the

✍ Flynn, Jacqueline K.; Paukovics, Geza; Moore, Miranda S.; Ellett, Anne; Gray, La 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 988 KB